// App-Quantinova.ai

S2042 2016 AHA : The Impact of Insulin Provision vs. Insulin Sensitization Therapy on the Risk of Myocardial Infarction in Diabetic Smokers With Stable Ischemic Heart Disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial

Researchers

Presenter

  • Matthew J. Chung

Principal Investigators

  • Eric Novak

  • David L. Brown

Medical Centers

  • Washington University in St Louis, St. Louis, MO

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Coronary Artery Disease

  • Myocardial infarction

  • Diabetes

  • Venous thrombosis

  • Stable coronary artery disease

Biomarkers

  • Plasminogen activator ihnibitor-1

  • Insulin

Drug/Treatment

  • BARI

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved